Investors Land ARWR Even Cheaper Than Its Secondary Stock Offering
March 12, 2024 at 15:11 PM EDT
Looking back to 69 days ago, Arrowhead Pharmaceuticals Inc (ARWR) priced a 15,790,000 share secondary stock offering at $28.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..